This page brings together the Agency's latest information on HIV and AIDS. It lists:
How EMA supports the global response to HIV
|
This is a summary of the European public assessment report (EPAR) for Odefsey. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It...
This is a summary of the European public assessment report (EPAR) for Ritonavir Mylan. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of...
Pifeltro is an antiviral medicine used to treat adults infected with human immunodeficiency virus type 1 (HIV-1), a virus that causes acquired immune deficiency syndrome (AIDS). Pifeltro is used...
This is a summary of the European public assessment report (EPAR) for Tenofovir disoproxil Zentiva. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its...
Delstrigo is an antiviral medicine used to treat adults infected with human immunodeficiency virus type 1 (HIV-1), a virus that causes acquired immune deficiency syndrome (AIDS). Delstrigo contains...
While EMA review is ongoing, dolutegravir should not be used in women seeking to become pregnant The European Medicines Agency (EMA) is evaluating preliminary results from a study which found 4 cases of birth defects such as spina bifida (malformed...
Eleven medicines recommended for approval, including one advanced therapy medicine The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) recommended eleven medicines, including one advanced therapy medicinal product (...
Truvada to enhance existing HIV prevention strategies The European Medicines Agency (EMA) has recommended granting a marketing authorisation in the European Union (EU) for Truvada (emtricitabine / tenofovir disoproxil) for pre-exposure prophylaxis (...
EMA recommends removal of class warnings for several medicines The European Medicines Agency (EMA) has updated the advice on the risk of body fat changes and lactic acidosis with medicines for the treatment of human immunodeficiency virus (HIV)...
